KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Ionis Pharmaceuticals (IONS) Inventory Average (2018 - 2025)

Historic Inventory Average for Ionis Pharmaceuticals (IONS) over the last 8 years, with Q3 2025 value amounting to $9.5 million.

  • Ionis Pharmaceuticals' Inventory Average fell 6685.44% to $9.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $9.5 million, marking a year-over-year decrease of 6685.44%. This contributed to the annual value of $10.0 million for FY2024, which is 3230.3% down from last year.
  • According to the latest figures from Q3 2025, Ionis Pharmaceuticals' Inventory Average is $9.5 million, which was down 6685.44% from $10.0 million recorded in Q2 2025.
  • In the past 5 years, Ionis Pharmaceuticals' Inventory Average ranged from a high of $29.5 million in Q2 2024 and a low of $9.5 million during Q3 2025
  • For the 5-year period, Ionis Pharmaceuticals' Inventory Average averaged around $20.9 million, with its median value being $22.1 million (2021).
  • In the last 5 years, Ionis Pharmaceuticals' Inventory Average skyrocketed by 2648.8% in 2023 and then plummeted by 6685.44% in 2025.
  • Over the past 5 years, Ionis Pharmaceuticals' Inventory Average (Quarter) stood at $23.9 million in 2021, then fell by 10.6% to $21.3 million in 2022, then fell by 22.5% to $16.5 million in 2023, then increased by 23.85% to $20.5 million in 2024, then plummeted by 53.74% to $9.5 million in 2025.
  • Its Inventory Average was $9.5 million in Q3 2025, compared to $10.0 million in Q2 2025 and $12.0 million in Q1 2025.